Blister Clinical Trial
Official title:
Feasibility Study to Evaluate the Safety and Performance of a Hydrogel Blister Patch Prototype for the Treatment of Foot Blisters
Study to evaluate the safety and performance of a new blister patch intended to treat blisters on the heel of the foot.
The study will require participation for up to 14 days of participation or less if the blister heals sooner, will recruit 100 subjects with fluid filled blisters on the heel of the foot that are intact and not broken. Some subjects will be asked to have their blisters photographed. All subjects will be required to have their blister unroofed (top layer of skin removed by the physician using sterile instruments). All subjects will receive study product, either test product or a marketed product. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04308889 -
Pro-Resolving Mediators in Acute Inflammation in Humans
|
Early Phase 1 | |
Completed |
NCT02810002 -
Assessing Foot Injuries in Infantry Recruits Wearing Different Boots
|
Phase 1/Phase 2 | |
Completed |
NCT05378997 -
Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.
|
Phase 1 | |
Completed |
NCT01120808 -
Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)
|
Phase 1 |